Benzinga's Top Upgrades
Analysts at Oppenheimer upgraded OvaScience, Inc. (NASDAQ: OVAS) from Market Perform to Outperform, according to Bloomberg. The price target for OvaScience is set to $55. OvaScience's shares closed at $40.51 yesterday.
Latest Ratings for OVAS
|Aug 2016||JP Morgan||Maintains||Neutral|
|Jan 2016||Credit Suisse||Initiates Coverage on||Underperform|
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.